CHA issued a letter of support for H.R. 6071, the SERV Communities Act.
The federal 340B program supports children's hospitals in their mission to serve low-income, uninsured and under-insured patients.
CHA joined the 340B Coalition and allied hospital groups and submitted joint comments in response to the Department of Health and Human Services’ ...
CHA prepared a high-level summary of the Blueprint to lower drug prices and reduce out-of-pocket costs. Member hospitals are encouraged to review it ...
This week CHA sent a letter thanking leaders of the Senate H.E.L.P committee for the inclusion of pediatric measures within S.2680.
A comparison of the recent legislative proposals relating to the 340B Drug Pricing Program.
On Feb. 16, CHA sent a letter to Reps. Larry Buschon, R-Ind., and Scott Peters, D-Calif., expressing concerns with H.R. 4710, the 340B Protecting ...
A summary of H.R. 4710, the 340B PAUSE Act, which proposes a two-year moratorium on new DSH hospitals and new DSH hospital child sites.
The 340B Drug Pricing Program allows eligible health care organizations to purchase outpatient drugs at discounted prices. The following children's ...
S.2312, the HELP Act, proposed a two-year moratorium on new 340B DSH child sites.
CHA and allies applaud the FDA's recent draft guidance on the Clarification of Orphan Designation of Drugs and Biologics for Pediatric Subpopulations ...
CHA comments on the delayed 340B ceiling price and manufacturer civil monetary penalties regulation from Oct. 1 to July 1, 2018.
CHA, in conjunction with allied provider and disease groups, sent a letter to House and Senate leadership within the Energy and Commerce Committee ...
CHA, in coordination with the 340B Coalition, submitted comments to the Health Resources and Services Administration (HRSA) on the proposed ...
The 340B Coalition submitted supplemental comments on the proposed rule addressing the ceiling price and manufacturer civil monetary penalties.
Children's hospitals are working together to address drug pricing and drug shortages to improve affordability and access to lifesaving drugs.
CHA submitted comments to the House Committee on Energy & Commerce to provide feedback on changes to Medicare payment policies included in the ...
Alston & Bird, LLP, prepared a presentation for CHA members on Medicare off-campus provider-based requirements.
During the summer and fall of 2015, the Policy Analysis team reached out to government relations professionals to inform our understanding of the ...
CHA submitted comments to HRSA in response to the proposed 340B omnibus guidance.
CHA and the AAMC held a joint webinar reviewing the implications of the proposed 340B omnibus guidance.
HRSA issued a proposed omnibus guidance to provide clarity on the current 340B Drug Pricing Program guidelines.
HRSA issued a proposed rule for all drug manufacturers under the 340B program addressing ceiling price calculations and civil monetary penalties.
Brief summary of a hearing to analyze the 340B program and hear from HRSA and related agencies.
Freestanding children's hospitals must meet certain qualifications and criteria to participate in the 340B Drug Discount Program.
Government Relations Toolkit
CHA members can view and print the latest materials for outreach to federal and state lawmakers.
Members receive the latest updates and suggest ways to best influence policy issues that impact children's health and children's hospitals in a weekly conference call.
Champions for Children's Health
©Children's Hospital Association